CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Linagliptin reduces ischemic brain damage following stroke in a high-fat diet mouse model: A comparison to Glimepiride
DOI 10.1055/s-0033-1341717
Bibliografische Angaben
Nachweis in CareLit
Autor:innenV Darsalia, A Olverling, H Ortsäter, T Klein, Å Sjöholm, C Patrone
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Type 2 Diabetes (T2D) is a major risk factor for premature and severe stroke. Linagliptin is a dipeptidyl peptidase (DPP)-4 inhibitor with unique pharmacological properties approved for the treatment of T2D. The aim of this study was to determine the efficacy of linagliptin in protecting against stroke-induced ischemic brain damage in a diabetic animal model. Methods: C57BL/6J male mice fed a high-fat diet for…
Zitieren
Zitierempfehlung
V Darsalia, A Olverling, H Ortsäter, T Klein, Å Sjöholm, C Patrone (2013) Linagliptin reduces ischemic brain damage following stroke in a high-fat diet mouse model: A comparison to Glimepiride. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0033-1341717
Mit CareLit weiterarbeiten